tert-Butyl (4R-cis)-6-formaldehydel-2,2-dimethyl-1,3-dioxane-4-acetate

tert-Butyl (4R-cis)-6-formaldehydel-2,2-dimethyl-1,3-dioxane-4-acetate Suppliers list
Company Name: Shandong Zircon Biotechnology Co., LTD  Gold
Tel: 18105366931 18348401771
Email: sdgs66880531@163.com
Company Name: JIANGXI AIFEIMU TECHNOLOGY CO.,LTD  Gold
Tel: 793-33899567 13735087952
Email: sales@afmpharm.com
Company Name: Jiangsu Greature Bio-Medicine Co., Ltd.  Gold
Tel: 0512-85557988 18662338937
Email: frank.wang@greature.com.cn
Company Name: Beijing Hope International Pharmaceutical Technology Development Co., Ltd  Gold
Tel: 01067886402 15600038801
Email: wuhangjin@hopelife.cn
Company Name: Shandong Meiao Huawei Technology Co., LTD  Gold
Tel: 0531-88682301 18595278766
Email: yuhongmeng@mayowell.com

tert-Butyl (4R-cis)-6-formaldehydel-2,2-dimethyl-1,3-dioxane-4-acetate manufacturers

tert-Butyl (4R-cis)-6-formaldehydel-2,2-dimethyl-1,3-dioxane-4-acetate Basic information
Product Name:tert-Butyl (4R-cis)-6-formaldehydel-2,2-dimethyl-1,3-dioxane-4-acetate
Synonyms:(3R,5S)-6-Oxo-3,5-O-diisopropylidene-3,5-dihydroxyhexanoic acid tert-butyl ester;tert-Butyl (4R-cis)-6-ForMaldehydel-2,2-diMethyl-1,3-dioxane-4-acetate DISCONTINUED. See H946660;(4R-Cis)-6-ForMaldehydel-2,2-diMethyl-1,3-dioxane-4-acetic acid,1,1-diMenthylethyl ester;tert-Butyl [(4R, 6S)-6-forMyl-2,2-diMethyl-1,3-dioxan-4-yl]acetate;InterMediate of Pitavastatin or Rosuvastatin;Rosuvastatin calciuM interMediate-D7;TERT-BUTYL (3R,5S)-6-OXO-3,5-O-ISO-PROPYLIDENE-3,5-DIHYDROXYHEXANOATE;(4R-cis)-6-Formaldehydel-2,2-dimethyl-1,3-dioxane-4-acetic acid 1,1-dimethylethyl ester
CAS:124752-23-4
MF:C13H22O5
MW:258.31
EINECS:1308068-626-2
Product Categories:Chiral Reagents;Heterocycles;Intermediates & Fine Chemicals;Pharmaceuticals;Pharmaceutical intermediates;INTERMEDIATES OF ROSUVASTATIN
Mol File:124752-23-4.mol
tert-Butyl (4R-cis)-6-formaldehydel-2,2-dimethyl-1,3-dioxane-4-acetate Structure
tert-Butyl (4R-cis)-6-formaldehydel-2,2-dimethyl-1,3-dioxane-4-acetate Chemical Properties
Boiling point 320.3±32.0 °C(Predicted)
density 1.073±0.06 g/cm3(Predicted)
storage temp. Inert atmosphere,Store in freezer, under -20°C
AppearanceWhite to off-white Solid
InChIInChI=1S/C13H22O5/c1-12(2,3)18-11(15)7-9-6-10(8-14)17-13(4,5)16-9/h8-10H,6-7H2,1-5H3/t9-,10+/m1/s1
InChIKeyJEFQIIXBSQLRTF-ZJUUUORDSA-N
SMILESO1[C@@H](CC(OC(C)(C)C)=O)C[C@@H](C=O)OC1(C)C
Safety Information
MSDS Information
tert-Butyl (4R-cis)-6-formaldehydel-2,2-dimethyl-1,3-dioxane-4-acetate Usage And Synthesis
Usestert-Butyl (4R-cis)-6-formaldehydel-2,2-dimethyl-1,3-dioxane-4-acetate can be used as intermediate used in the synthesis of statins.
Synthesis
(4R-Cis)-6-Hydroxymethyl-2,2-dimethyl-1,3-dioxane-4-acetic acid 1,1-dimethylethyl ester

124655-09-0

tert-Butyl (4R-cis)-6-formaldehydel-2,2-dimethyl-1,3-dioxane-4-acetate

124752-23-4

General procedure for the synthesis of tert-butyl (4R,6S)-6-formyl-2,2-dimethyl-1,3-dioxane-4-acetate from (4R,6S)-6-hydroxymethyl-2,2-dimethyl-1,3-dioxane-4-acetate: tert-butyl (4R,6S)-6-hydroxymethyl-2,2-dimethyl-1,3-dioxane-4-acetate ( 10.0 g, 0.0385 mol) was dissolved in a solvent mixture of dimethyl sulfoxide (15.0 g, 0.192 mol) and dichloromethane (100 mL) and the reaction system was subsequently cooled to 0 to -5 °C. After being maintained at this temperature for 15 minutes, diisopropylethylamine (17.42 g, 0.1347 mol) was slowly added and stirring was continued at 0 to -5 °C for 15 minutes. Another flask was taken and a suspension was prepared by sequentially adding pyridine-sulfur trioxide complex (12.25 g, 0.077 mol), pyridine (6.09 g, 0.077 mol) and dimethyl sulfoxide (15.0 g, 0.192 mol) at room temperature and stirring for 10 minutes. This suspension was slowly added to the aforementioned cooled dichloromethane solution, keeping the reaction temperature at 0 to -5°C and continuing to stir for 1 hour. Upon completion of the reaction, the reaction was quenched by the addition of water (50.0 mL) and stirred for 10 minutes. Liquid-liquid separation was then performed and the aqueous phase was back-extracted with dichloromethane (2 x 20 mL). The organic phases were combined, washed sequentially with water (3 x 100.0 mL), dried over anhydrous sodium sulfate, and concentrated under reduced pressure to remove the solvent to give the crude product. The crude product was dried under reduced pressure at 40 to 45 °C for 1 h. The final product was tert-butyl (4R,6S)-6-formyl-2,2-dimethyl-1,3-dioxohexane-4-acetate (9.22 g, 93.0% yield).

References[1] Tetrahedron Letters, 1990, vol. 31, # 18, p. 2545 - 2548
[2] Patent: WO2008/59519, 2008, A2. Location in patent: Page/Page column 12; 18; 23
[3] Indian Journal of Chemistry - Section B Organic and Medicinal Chemistry, 2015, vol. 54B, # 10, p. 1247 - 1251
[4] Patent: WO2005/56004, 2005, A1. Location in patent: Page/Page column 52; 145-146
[5] Patent: CN105503816, 2016, A. Location in patent: Paragraph 0066; 0067; 0068
Tag:tert-Butyl (4R-cis)-6-formaldehydel-2,2-dimethyl-1,3-dioxane-4-acetate(124752-23-4) Related Product Information
2-Butoxyethanol tert-Butyl bromoacetate Isobutyl acetate Dimethylbenzylcarbinyl acetate Ethyl 2-(Chlorosulfonyl)acetate Dimethyl ether Dimethyl carbonate tert-Butyl acetate DL-sec-Butyl acetate tert-Butyl peroxyacetate tert-Butyl chloroacetate Methyl 2,2-dimethylphenylacetate Dimethyl fumarate Dimethyl sulfoxide N,N-Dimethylformamide Ethane Butyl oleate Butyl acetate